You are here
News and Events
For an overview of the latest news, press releases and blog posts from Cancer Research UK visit the Cancer News page.
Below you will find the latest press releases, news and event information from the Cancer Research UK Commercial Partnerships team and our legal entity, Cancer Research Technology (CRT).
|30 January 2012||Curis Announces FDA Approval of Erivedge (vismodegib) Capsule as First Treatment for Advanced BCC|
|15 December 2011||Call for Reagents|
|15 December 2011||Stephen Friend visits CRT to discuss Arch2POCM|
|15 December 2011||FEATURE: Successful Discovery Committee grant application shows promise for novel drug combinations|
|15 December 2011||FEATURE: CRT reflects on a successful NCRI conference|
|15 December 2011||FEATURE: CCR4 - from target discovery to a license and sponsored collaboration with Affitech|
|1 September 2011||CRT's Discovery Laboratory Autotaxin programme progresses to Lead Optimisation|
|19 August 2011||Preclinical Development Candidate selected for Chk1 Inhibitor Programme|
|28 July 2011||FEATURE: Abiraterone receives approval from FDA to be marketed as a prostate cancer therapy - Zytiga|
|28 July 2011||FEATURE: BliNK Therapeutics, our 24th spin-out company is formed|